Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

2.12
-0.0500-2.30%
Post-market: 2.160.0385+1.82%19:59 EST
Volume:6.26M
Turnover:12.77M
Market Cap:269.41M
PE:-4.59
High:2.17
Open:2.12
Low:1.91
Close:2.17
52wk High:4.31
52wk Low:0.8411
Shares:127.08M
Float Shares:79.22M
Volume Ratio:1.74
T/O Rate:7.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4618
EPS(LYR):-0.4673
ROE:-41.01%
ROA:-22.88%
PB:2.31
PE(LYR):-4.54

Loading ...

Nautilus Biotechnology price target raised to $4 from $3.50 at Roth Capital

TIPRANKS
·
Oct 28

Avantor Raises FY Revenue Growth, Profit Guidance After Q3 Beat

Reuters
·
Oct 28

Government-Funded IP Could Limit Nautilus Biotechnology’s Control, Commercialization and Competitive Edge

TIPRANKS
·
Oct 28

Nautilus Biotechnology, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
Oct 27

Kiniksa Pharmaceuticals Q3 Arcalyst Revenue Jumps 58%; Raises Guidance

Reuters
·
Oct 27

Repligen Q3 Revenue Beats Estimates on Higher Demand; Lifts Outlook

Reuters
·
Oct 27

Nautilus Biotechnology Q3 Revenue Beats

Reuters
·
Oct 27

Nautilus Expects up to $6 Million from ARPA-H-Funded SEEDS Project

Reuters
·
Oct 27

Nautilus Biotechnology Q3 EPS USD -0.12

Reuters
·
Oct 27

Nautilus Biotechnology Q3 Operating Expenses USD 16.947 Million

THOMSON REUTERS
·
Oct 27

Press Release: Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

Dow Jones
·
Oct 27

Nautilus Biotechnology, Inc. Expected to Post a Loss of 14 Cents a Share - Earnings Preview

Reuters
·
Oct 23

Nautilus Biotechnology Publishes Update to Financial Calendar

Reuters
·
Oct 15

Nautilus Biotechnology Initiated at Buy by Roth Capital

Dow Jones
·
Sep 29

Nautilus Biotechnology May Offer up to $300 Million of Securities - SEC Filing

Reuters
·
Sep 12

Nautilus Biotechnology files $300M mixed securities shelf

TIPRANKS
·
Sep 12

Nautilus Biotechnology Signs TD Cowen for up to USD 125 Million ATM Equity Offering

Reuters
·
Sep 12

Nautilus Biotechnology - May Offer up to $125 Mln Common Stock Under Sales Agreement with TD Securities - SEC Filing

THOMSON REUTERS
·
Sep 12

Leerink Partners Initiates Coverage on Nautilus Biotechnolgy With Outperform Rating, $4 Price Target

MT Newswires Live
·
Sep 09

Nautilus Biotechnology initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09